Literature DB >> 17084539

Functional outcome and survival after radiotherapy of metastatic spinal cord compression in patients with cancer of unknown primary.

Dirk Rades1, Fabian Fehlauer, Theo Veninga, Lukas J A Stalpers, Hiba Basic, Peter J Hoskin, Volker Rudat, Johann H Karstens, Steven E Schild, Juergen Dunst.   

Abstract

PURPOSE: Patients with cancer of unknown primary (CUP) account for about 10% of patients with metastatic spinal cord compression (MSCC). This study aims to define the appropriate radiation regimen for these patients. METHODS AND MATERIALS: Data of 143 CUP patients irradiated for MSCC were retrospectively evaluated. Short-course radiotherapy (RT) (1x8 Gy, 5x4 Gy, n = 68) and long-course RT (10x3 Gy, 15x2.5 Gy, 20x2 Gy, n = 75) plus 8 further potential prognostic factors (age, gender, performance status, visceral metastases, other bone metastases, number of involved vertebrae, ambulatory status, time of developing motor deficits before RT) were compared for functional outcome and survival.
RESULTS: Improvement of motor function occurred in 10% of patients, no further progression of motor deficits in 57%, and deterioration in 33%. On multivariate analysis, functional outcome was positively associated with slower development of motor deficits (p < 0.001), absence of visceral metastases (p = 0.008) and other bone metastases (p = 0.027), and ambulatory status (p = 0.054), not with the radiation regimen (p = 0.74). Recurrence of MSCC in the irradiated region occurred in 7 patients after median 6 months. Median survival was 4 months. On multivariate analysis, better survival was significantly associated with absence of visceral metastases (p < 0.001), absence of other bone metastases (p = 0.005), ambulatory status (p = 0.001), and slower development of motor deficits (p = 0.030).
CONCLUSIONS: For MSCC treatment in patients with CUP, no significant difference was observed between short-course and long-course RT regarding functional outcome and survival. Short-course RT appears preferable, at least for patients with a poor predicted survival, as it is more patient convenient and more cost-effective.

Entities:  

Mesh:

Year:  2006        PMID: 17084539     DOI: 10.1016/j.ijrobp.2006.08.047

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  11 in total

Review 1.  [Radiotherapeutic concepts in cancer of unknown primary site].

Authors:  D Krug; J Debus; F Sterzing
Journal:  Radiologe       Date:  2014-02       Impact factor: 0.635

2.  Metastatic spinal cord compression in non-small cell lung cancer patients. Prognostic factors in a series of 356 patients.

Authors:  D Rades; S Douglas; T Veninga; A Bajrovic; L J A Stalpers; P J Hoskin; V Rudat; S E Schild
Journal:  Strahlenther Onkol       Date:  2012-02-25       Impact factor: 3.621

3.  Metastatic spinal cord compression in patients with cancer of unknown primary. Estimating the survival prognosis with a validated score.

Authors:  S Douglas; S E Schild; D Rades
Journal:  Strahlenther Onkol       Date:  2012-09-29       Impact factor: 3.621

Review 4.  The treatment of spinal metastases.

Authors:  Karl-Stefan Delank; Clemens Wendtner; Hans Theodor Eich; Peer Eysel
Journal:  Dtsch Arztebl Int       Date:  2011-02-04       Impact factor: 5.594

5.  Radiation-induced changes in peripheral nerve by stereotactic radiosurgery: a study on the sciatic nerve of rabbit.

Authors:  Zhixiong Lin; Vincent W C Wu; Wenchui Ju; Yoshiya Yamada; Longhua Chen
Journal:  J Neurooncol       Date:  2010-07-22       Impact factor: 4.130

6.  DEGRO practice guidelines for palliative radiotherapy of metastatic breast cancer: bone metastases and metastatic spinal cord compression (MSCC).

Authors:  Rainer Souchon; Frederik Wenz; Felix Sedlmayer; Wilfried Budach; Jürgen Dunst; Petra Feyer; Wulf Haase; Wolfgang Harms; Marie-Luise Sautter-Bihl; Rolf Sauer
Journal:  Strahlenther Onkol       Date:  2009-08-28       Impact factor: 3.621

7.  Metastatic spinal cord compression as a result of the unknown primary tumour.

Authors:  N A Quraishi; D Ramoutar; D Sureshkumar; S R Manoharan; A Spencer; G Arealis; K L Edwards; B M Boszczyk
Journal:  Eur Spine J       Date:  2014-04-02       Impact factor: 3.134

8.  Prognostic factors for different outcomes in patients with metastatic spinal cord compression from cancer of unknown primary.

Authors:  Sarah Douglas; Stefan Huttenlocher; Amira Bajrovic; Volker Rudat; Steven E Schild; Dirk Rades
Journal:  BMC Cancer       Date:  2012-06-21       Impact factor: 4.430

9.  Metastatic spinal cord compression as the first sign of malignancy.

Authors:  Johan Wänman; Pawel Grabowski; Helena Nyström; Patrik Gustafsson; Anders Bergh; Anders Widmark; Sead Crnalic
Journal:  Acta Orthop       Date:  2017-05-11       Impact factor: 3.717

10.  Surgery in Acute Metastatic Spinal Cord Compression: Timing and Functional Outcome.

Authors:  Hanno S Meyer; Arthur Wagner; Alessandra Raufer; Ann-Kathrin Joerger; Jens Gempt; Bernhard Meyer
Journal:  Cancers (Basel)       Date:  2022-04-30       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.